Meta-Analysis
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Nov 27, 2024; 16(11): 3546-3558
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3546
Table 1 Characteristics of the included studies
Ref.
Country
Number of included studies
Sample size
Supplementation time
Type of supplementation
Risk of bias tool, No. of high quality/total studies
Percentage of high-quality studies (%)
Investigated outcomes
Quality
Zeng et al[32], 2021China191975PreoperativeMulti-strain Probiotics and synbioticsCochrane, 19/19100Total infections, UTIs, bacteremia, sepsis, SSIs, pneumonia, central line infection, peritoneal infection, intra-abdominal infectionHigh
Amitay et al[25], 2020Germany11NRPreoperativeMulti-strain Probiotics and synbioticsNHBLI tool, 1/119Total infections, sepsisHigh
Rueda-Robles et al[43], 2022Brazil131535Pre- and postoperativeMulti-strain Probiotics and synbioticsJoanna Briggs Institute’s critical assessment tools, 2/1315Sepsis, SSIs, pneumonia, intra-abdominal infectionHigh
Ye et al[31], 2023China161798PreoperativeMulti-strain Probiotics and synbioticsJadad, 16/16100SSIs, pneumoniaHigh
He et al[29], 2013China6361PreoperativeMulti-strain Probiotics and synbioticsJadad, 5/683Total infections, sepsis, SSIs, pneumonia, peritoneal infection, abdominal infectionHigh
An et al[26], 2022Korea201763PreoperativeMulti-strain Probiotics and synbioticsCochrane, 6/2030UTIs, bacteremia, SSIs, pneumoniaHigh
de Andrade Calaça et al[28], 2017Brazil7821Pre- and postoperativeMulti-strain ProbioticsNRNRTotal infections, Bacteremia, SSIsModerate
Chen et al[27], 2020China6803PreoperativeMulti-strain ProbioticsJadad, 6/6100Total infections, UTIs, sepsis, SSIs, pneumonia, central line infectionModerate
Persson et al[30], 2024Brazil101276Pre- and postoperativeMulti-strain ProbioticsNRNRUTIs, SSIs, pneumoniaModerate
Ouyang et al[19], 2019China131186Pre- and postoperativeMulti-strain ProbioticsCochrane, 11/1384Total infections, UTIs, SSIs, pneumoniaModerate
Chen et al[3], 2024China10NRPreoperativeMulti-strain ProbioticsCochrane, 2/1020SSIsModerate